| Identification of prognostic biomarkers for response to radiotherapy by DNA microarray in nasopharyngeal carcinoma patients. | |
| | |
MedLine Citation:
|
PMID: 22267178 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Nasopharyngeal carcinoma (NPC) is a malignancy with an unusually variable incidence rate across the world. Radiotherapy is the primary treatment modality for NPC, but radiation resistance remains a serious obstacle to successful treatment in many cases. To identify the genes involved in this resistance and to find molecular markers for predicting NPC response to radiotherapy, we compare the expression profiles of 12 radiation-resistant patient biopsy specimens and 8 radiation-sensitive patient biopsy specimens using DNA microarray, containing 14112 human unigenes. A total of 111 aberrantly expressed genes were identified, of which ZNF608 and CSF1R were up-regulated in the radiation-resistant NPC compared with radiation-sensitive NPC, and the results were confirmed by real-time RT-PCR in 17 independent NPC patient specimens. Biostatistics and bioinformatics analyses were performed to detect the potential pathway underling this resistance, 26 pathways (9 categories) were found probably associated with radiation-resistant NPC, such as cell ion homeostasis, cell proliferation, receptor protein signalling, membrane system, humoral immune response, as well as cytokines and inflammation. We suggest the radiation-resistant capacity of NPC was mostly due to the change of cell Ca2+ homeostasis promoting anti-apoptosis, DNA repair and rescuing tumour cells under radiation therapy. Cell proliferation promotion induced by extracellular and intracellular factors may maintain tumour size under radiotherapy leading to recurrence after treatment. Our study reveals that at least 2 ectopically expressed genes play important roles in prognosis of NPC radiotherapy and may serve as potential targets for novel radiation therapeutic strategies in the future. |
| | |
Authors:
|
Shu Yang; Jiaxin Chen; Yi Guo; Hui Lin; Zheng Zhang; Guosheng Feng; Yanrong Hao; Jinjian Cheng; Ping Liang; Kehe Chen; Hai Wu; Yao Li |
Related Documents
:
|
23170278 - Ipilimumab in a phase ii trial of melanoma patients with brain metastases. 21715318 - High single drug activity of nelarabine in relapsed t-lymphoblastic leukemia/lymphoma o... 22017858 - Oral cavity squamous cell carcinoma metastasis to the submandibular gland. 65728 - Cyclophosphamide, vincristine, and prednisone (cvp) versus adriamycin, bleomycin, and p... 9787148 - High-dose therapy and autologous peripheral blood stem cell transplantation in multiple... 8632558 - Primary chemotherapy in patients with nonseminomatous germ cell tumors of the testis an... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-1-20 |
Journal Detail:
|
Title: International journal of oncology Volume: - ISSN: 1791-2423 ISO Abbreviation: - Publication Date: 2012 Jan |
Date Detail:
|
Created Date: 2012-1-23 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9306042 Medline TA: Int J Oncol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Life State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Science, Fudan University, Shanghai, P.R. China. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Use of a TTA Plate for Correction of Severe Patella Baja in a Chihuahua.
Next Document: A p.D116G mutation in CREB1 leads to novel multiple malformation syndrome resembling CrebA knockout ...